Study reports that thyroglobulin autoantibodies do not affect survival in differentiated thyroid carcinoma, suggesting careful monitoring instead of overtreatment.
The presence of TgAb did not influence the outcome regarding overall and disease-free survival. Results implicate that the initial appearance of TgAb does not influence the outcome of patients with DTC. Patients with positive TgAb should be monitored closely during follow-up as Tg measurement is unreliable, while overtreatment should be avoided.
No takes yet. Share an insight, caveat, or question.
Bornemann et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: